Cancer Genetics (CGIX) Misses Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Cancer Genetics, Inc. Announces Strong Third Quarter and Year-to Date 2015 Results
November 10, 2015 7:30 AM ESTThird Quarter Revenues up 24 Percent Year-over-YearRevenues for Nine Months Ended September 30, 2015 up 104 Percent Year-over-YearGross Profit Margins Doubled for the First Nine Months of 2015 to 26% from 13% for the First Nine Months of 2014Closed on Acquisition of Operations & Assets of Response Genetics, Inc. (RGI) Expected to Add An Additional $10-$12 Million in Annual RevenueProvides Opportunity to Add & Accelerate Additional Contracts for Clinical Trials Priced Public Offering Expected to Result in Gross Proceeds of $12 Million to CGI
RUTHERFORD, N.J.,... More
